Cargando…
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria
BACKGROUND: Proteinuria is associated with many glomerular diseases and a risk factor for the progression to renal failure. We previously showed that heparanase (HPSE) is essential for the development of proteinuria, whereas peroxisome proliferator-activated receptor ɣ (PPARɣ) agonists can ameliorat...
Autores principales: | Garsen, Marjolein, Buijsers, Baranca, Sol, Marloes, Gockeln, Lena, Sonneveld, Ramon, van Kuppevelt, Toin H., de Graaf, Mark, van den Born, Jacob, Kamps, Jan A.A.M., van Raalte, Daniël H., van der Meer, Rutger W., Lamb, Hildo J., Hillebrands, Jan-Luuk, Rabelink, Ton J., Maciej-Hulme, Marissa L., Krenning, Guido, Nijenhuis, Tom, van der Vlag, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043778/ https://www.ncbi.nlm.nih.gov/pubmed/36889064 http://dx.doi.org/10.1016/j.ebiom.2023.104506 |
Ejemplares similares
-
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
por: Buijsers, Baranca, et al.
Publicado: (2023) -
Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
por: Gil, Natali, et al.
Publicado: (2012) -
Increased Plasma Heparanase Activity in COVID-19 Patients
por: Buijsers, Baranca, et al.
Publicado: (2020) -
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis
por: Buijsers, Baranca, et al.
Publicado: (2023) -
Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria
por: Garsen, Marjolein, et al.
Publicado: (2016)